Merck & Company (MRK)
82.50 x 3 82.80 x 3
Post-market by (Cboe BZX)
82.74 +2.90 (+3.63%) 04/25/25 [NYSE]
82.50 x 3 82.80 x 3
Post-market 82.55 -0.19 (-0.23%) 19:46 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,133,000 | 377,000 | 14,526,000 | 12,358,000 | 4,523,000 |
| Depreciation Amortization | 4,499,000 | 3,872,000 | 3,909,000 | 3,214,000 | 3,486,000 |
| Income taxes - deferred | -1,249,000 | -1,899,000 | -1,568,000 | 187,000 | -566,000 |
| Accounts receivable | -244,000 | -1,148,000 | -644,000 | -2,033,000 | -1,002,000 |
| Accounts payable and accrued liabilities | 182,000 | -380,000 | -289,000 | 405,000 | 684,000 |
| Other Working Capital | -3,667,000 | -2,205,000 | -2,782,000 | -3,839,000 | -4,601,000 |
| Other Operating Activity | 4,814,000 | 14,389,000 | 5,943,000 | 2,830,000 | 5,093,000 |
| Operating Cash Flow | $21,468,000 | $13,006,000 | $19,095,000 | $13,122,000 | $7,617,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -142,000 | 703,000 | -483,000 | 1,025,000 | 2,717,000 |
| PPE Investments | -3,372,000 | -3,863,000 | -4,388,000 | -4,448,000 | -4,429,000 |
| Net Acquisitions | -4,093,000 | -12,032,000 | N/A | -12,907,000 | -6,606,000 |
| Sale Of Investment | N/A | 1,145,000 | N/A | N/A | N/A |
| Other Investing Activity | -127,000 | -36,000 | -89,000 | -91,000 | -875,000 |
| Investing Cash Flow | $-7,734,000 | $-14,083,000 | $-4,960,000 | $-16,421,000 | $-9,193,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -3,986,000 | 2,549,000 |
| Debt Issued | 3,599,000 | 5,939,000 | N/A | 7,936,000 | 4,419,000 |
| Debt Repayment | -1,290,000 | -1,755,000 | -2,251,000 | -2,319,000 | -1,957,000 |
| Common Stock Issued | 177,000 | 125,000 | 384,000 | 202,000 | 89,000 |
| Common Stock Repurchased | -1,306,000 | -1,346,000 | N/A | -840,000 | -1,281,000 |
| Dividend Paid | -7,840,000 | -7,445,000 | -7,012,000 | -6,610,000 | -6,215,000 |
| Other Financing Activity | -372,000 | -328,000 | -240,000 | 8,714,000 | -436,000 |
| Financing Cash Flow | $-7,032,000 | $-4,810,000 | $-9,119,000 | $3,097,000 | $-2,832,000 |
| Exchange Rate Effect | -293,000 | 23,000 | -410,000 | -133,000 | 253,000 |
| Beginning Cash Position | 6,909,000 | 12,773,000 | 8,167,000 | 8,153,000 | 9,934,000 |
| End Cash Position | 13,318,000 | 6,909,000 | 12,773,000 | 8,167,000 | 8,165,000 |
| Net Cash Flow | $6,409,000 | $-5,864,000 | $4,606,000 | $14,000 | $-1,769,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,468,000 | 13,006,000 | 19,095,000 | 13,122,000 | 7,617,000 |
| Capital Expenditure | -3,372,000 | -3,863,000 | -4,388,000 | -4,448,000 | -4,429,000 |
| Free Cash Flow | 18,096,000 | 9,143,000 | 14,707,000 | 8,674,000 | 3,188,000 |